ArticlePloS one2022

Clinical validation of a next-generation sequencing-based multi-cancer early detection "liquid biopsy" blood test in over 1,000 dogs using an independent testing set: The CANcer Detection in Dogs (CANDiD) study.

Andi Flory et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.